Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+7.23%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$39.9B
AUM Growth
+$1.35B
(+3.5%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-1.1%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
2,910
New
490
Increased
855
Reduced
1,229
Closed
318
Top Buys
| 1 |
Tesla
TSLA
|
+$398M |
| 2 |
NVIDIA
NVDA
|
+$370M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$334M |
| 4 |
Pfizer
PFE
|
+$323M |
| 5 |
Advanced Micro Devices
AMD
|
+$299M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$408M |
| 3 |
Snap
SNAP
|
+$379M |
| 4 |
Analog Devices
ADI
|
+$283M |
| 5 |
AT&T
T
|
+$279M |
Sector Composition
| 1 | Technology | 26.26% |
| 2 | Healthcare | 22.87% |
| 3 | Industrials | 9.09% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
ClearPoint Neuro
CLPT
$298M
| $652K | ﹤0.01% |
+58,100
| New | +$652K |
|
1777
NVR
NVR
$23.3B
| $650K | ﹤0.01% |
110
-400
| -78% | -$2.36M |
|
1778
Supernus Pharmaceuticals
SUPN
$2.55B
| $650K | ﹤0.01% |
22,300
+9,500
| +74% | +$277K |
|
1779
Donegal Group Class A
DGICA
$711M
| $646K | ﹤0.01% |
45,200
-4,300
| -9% | -$61.5K |
|
1780
Dorian LPG
LPG
$1.35B
| $646K | ﹤0.01% |
50,943
+1,700
| +3% | +$21.6K |
|
1781
Alnylam Pharmaceuticals
ALNY
$61.1B
| $644K | ﹤0.01% |
+3,800
| New | +$644K |
|
1782
Astec Industries
ASTE
$1.06B
| $644K | ﹤0.01% |
9,300
| – | – |
|
1783
Silvercrest Asset Management
SAMG
$137M
| $644K | ﹤0.01% |
37,500
+1,300
| +4% | +$22.3K |
|
1784
HNI Corp
HNI
$2.07B
| $643K | ﹤0.01% |
15,300
-7,200
| -32% | -$303K |
|
1785
Barnes & Noble Education
BNED
$277M
| $642K | ﹤0.01% |
942
-142
| -13% | -$96.8K |
|
1786
Bridgewater Bancshares
BWB
$457M
| $642K | ﹤0.01% |
36,300
+2,200
| +6% | +$38.9K |
|
1787
Mid Penn Bancorp
MPB
$691M
| $641K | ﹤0.01% |
20,200
-2,800
| -12% | -$88.9K |
|
1788
Westlake Corp
WLK
$11.3B
| $641K | ﹤0.01% |
6,600
-10,400
| -61% | -$1.01M |
|
1789
Qfin Holdings, Inc. American Depositary Shares
QFIN
$3.76B
| $640K | ﹤0.01% |
27,900
-158,200
| -85% | -$3.63M |
|
1790
First Bancorp
FBNC
$2.29B
| $638K | ﹤0.01% |
13,951
-48,349
| -78% | -$2.21M |
|
1791
Capital Bancorp
CBNK
$551M
| $637K | ﹤0.01% |
24,300
+11,900
| +96% | +$312K |
|
1792
Scansource
SCSC
$974M
| $637K | ﹤0.01% |
18,163
+5,100
| +39% | +$179K |
|
1793
DHT Holdings
DHT
$1.98B
| $636K | ﹤0.01% |
122,600
+28,000
| +30% | +$145K |
|
1794
Foster
FSTR
$291M
| $636K | ﹤0.01% |
46,254
+1,700
| +4% | +$23.4K |
|
1795
Hanmi Financial
HAFC
$748M
| $636K | ﹤0.01% |
26,842
-22,900
| -46% | -$543K |
|
|
SA
1796
Seabridge Gold
SA
$1.92B
| $635K | ﹤0.01% |
38,500
+19,900
| +107% | +$328K |
|
|
CBAY
1797
DELISTED
Cymabay Therapeutics
CBAY
| $633K | ﹤0.01% |
187,138
-196,600
| -51% | -$665K |
|
1798
LCNB Corp
LCNB
$223M
| $631K | ﹤0.01% |
32,300
+4,000
| +14% | +$78.1K |
|
1799
Phathom Pharmaceuticals
PHAT
$840M
| $631K | ﹤0.01% |
32,100
+15,700
| +96% | +$309K |
|
|
LTRPA
1800
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $630K | ﹤0.01% |
290,200
-235,200
| -45% | -$511K |
|